| |
|
|
| Name: |
Cormorant Asset Management LLC |
| City: |
BOSTON |
| State: |
MA |
| Zip: |
02110 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
19 |
|
View All Holdings |
Currently
Viewing:
Unchanged Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MLTX |
Multisys Language Solutions... |
1 |
- |
$0.00 |
$426,661,000 |
8,494,151 |
18.8% |
-86,301,000 |
0 |
14.171 |
N/A |
|
|
CRNX |
Crinetics Pharmaceuticals, ... |
11 |
- |
$45.33 |
$53,832,000 |
1,150,000 |
2.37% |
12,915,000 |
0 |
1.565 |
N/A |
|
|
BMEA |
Biomea Fusion, Inc. |
12 |
- |
$5.64 |
$53,385,000 |
3,570,872 |
2.35% |
1,536,000 |
0 |
12.412 |
N/A |
|
|
KRRO |
Korro Bio |
13 |
- |
$0.00 |
$47,625,000 |
529,170 |
2.1% |
22,262,000 |
0 |
1.573 |
N/A |
|
|
PHVS |
Pharvaris N V Ord Shs |
16 |
- |
$0.00 |
$39,552,000 |
1,711,460 |
1.74% |
-8,454,000 |
0 |
4.133 |
N/A |
|
|
ALXO |
Alx Oncology Holdings Inc |
19 |
- |
$0.00 |
$35,034,000 |
3,142,079 |
1.54% |
-11,752,000 |
0 |
6.307 |
N/A |
|
|
ABVX |
Abivax S.A |
23 |
- |
$13.58 |
$30,459,000 |
2,130,000 |
1.34% |
7,668,000 |
0 |
3.435 |
N/A |
|
|
MRNS |
Marinus Pharmaceuticals Inc |
25 |
- |
$1.47 |
$29,380,000 |
3,250,000 |
1.29% |
-5,948,000 |
0 |
5.838 |
N/A |
|
|
CRGX |
Cargo Therapeutics, Inc. |
29 |
- |
$0.00 |
$26,395,000 |
1,182,563 |
1.16% |
-981,000 |
0 |
0 |
N/A |
|
|
RYTM |
Rhythm Pharmaceuticals, Inc. |
30 |
- |
$42.77 |
$23,832,000 |
550,000 |
1.05% |
-1,452,000 |
0 |
0.775 |
N/A |
|
|
IDYA |
Ideaya Biosciences, Inc. |
33 |
- |
$0.00 |
$19,746,000 |
450,000 |
0.87% |
3,735,000 |
0 |
0.624 |
N/A |
|
|
INSM |
Insmed Inc |
37 |
- |
$63.92 |
$15,600,000 |
575,000 |
0.69% |
-2,219,000 |
0 |
0.379 |
Biotechnology |
|
|
IRON |
Disc Medicine, Inc |
48 |
- |
$46.27 |
$7,783,000 |
125,000 |
0.34% |
563,000 |
0 |
0.518 |
N/A |
|
|
CNTA |
Centessa Pharmaceuticals Plc |
49 |
- |
$0.00 |
$6,346,000 |
561,600 |
0.28% |
1,876,000 |
0 |
0.642 |
N/A |
|
|
GHRS |
Gh Research Ord Shs |
50 |
- |
$0.00 |
$6,322,000 |
593,043 |
0.28% |
2,882,000 |
0 |
1.214 |
N/A |
|
|
LNTH |
Lantheus Holdings, Inc. |
52 |
- |
$79.26 |
$4,668,000 |
75,000 |
0.21% |
18,000 |
0 |
0.104 |
N/A |
|
|
VERV |
Verve Therapeutics, Inc. |
53 |
- |
$0.00 |
$4,648,000 |
350,000 |
0.2% |
-231,000 |
0 |
0.435 |
N/A |
|
|
RAPT |
Rapt Therapeutics, Inc. |
54 |
- |
$3.32 |
$4,461,000 |
496,750 |
0.2% |
-7,883,000 |
0 |
1.376 |
N/A |
|
|
VYNE |
VYNE Therapeutics Inc |
55 |
- |
$0.22 |
$4,281,000 |
1,394,336 |
0.19% |
1,032,000 |
0 |
2.716 |
N/A |
|
